The economic burden of cancer in Korea in 2009

So Young Kim, Jong Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young Joo Won, Hong Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Cancer imposes a significant economic burden on individuals, families and society. The purpose of this study was to estimate the economic burden of cancer using the healthcare claims and cancer registry data in Korea in 2009. Materials and Methods: The economic burden of cancer was estimated using the prevalence data where patients were identified in the Korean Central Cancer Registry. We estimated the medical, non-medical, morbidity and mortality cost due to lost productivity. Medical costs were calculated using the healthcare claims data obtained from the Korean National Health Insurance (KNHI) Corporation. Non-medical costs included the cost of transportation to visit health providers, costs associated with caregiving for cancer patients, and costs for complementary and alternative medicine (CAM). Data acquired from the Korean National Statistics Office and Ministry of Labor were used to calculate the life expectancy at the time of death, age- and gender-specific wages on average, adjusted for unemployment and labor force participation rate. Sensitivity analysis was performed to derive the current value of foregone future earnings due to premature death, discounted at 3% and 5%. Results: In 2009, estimated total economic cost of cancer amounted to $17.3 billion at a 3% discount rate. Medical care accounted for 28.3% of total costs, followed by non-medical (17.2%), morbidity (24.2%) and mortality (30.3%) costs. Conclusions: Given that the direct medical cost sharply increased over the last decade, we must strive to construct a sustainable health care system that provides better care while lowering the cost. In addition, a comprehensive cancer survivorship policy aimed at lower caregiving cost and higher rate of return to work has become more important than previously considered.

Original languageEnglish
Pages (from-to)1295-1301
Number of pages7
JournalAsian Pacific Journal of Cancer Prevention
Volume16
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Korea
Economics
Costs and Cost Analysis
Neoplasms
Complementary Therapies
Delivery of Health Care
Registries
Morbidity
Premature Mortality
Return to Work
Unemployment
Mortality
Salaries and Fringe Benefits
National Health Programs
Life Expectancy
Health Care Costs
Survival Rate

Keywords

  • Cancer
  • Cost analysis
  • Cost of illness
  • Health care costs
  • Korea

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Kim, S. Y., Park, J. H., Kang, K. H., Hwang, I., Yang, H. K., Won, Y. J., ... Yoon, S-J. (2015). The economic burden of cancer in Korea in 2009. Asian Pacific Journal of Cancer Prevention, 16(3), 1295-1301. https://doi.org/10.7314/APJCP.2015.16.3.1295

The economic burden of cancer in Korea in 2009. / Kim, So Young; Park, Jong Hyock; Kang, Kyoung Hee; Hwang, Inuk; Yang, Hyung Kook; Won, Young Joo; Seo, Hong Gwan; Lee, Dukhyoung; Yoon, Seok-Jun.

In: Asian Pacific Journal of Cancer Prevention, Vol. 16, No. 3, 01.01.2015, p. 1295-1301.

Research output: Contribution to journalArticle

Kim, SY, Park, JH, Kang, KH, Hwang, I, Yang, HK, Won, YJ, Seo, HG, Lee, D & Yoon, S-J 2015, 'The economic burden of cancer in Korea in 2009', Asian Pacific Journal of Cancer Prevention, vol. 16, no. 3, pp. 1295-1301. https://doi.org/10.7314/APJCP.2015.16.3.1295
Kim SY, Park JH, Kang KH, Hwang I, Yang HK, Won YJ et al. The economic burden of cancer in Korea in 2009. Asian Pacific Journal of Cancer Prevention. 2015 Jan 1;16(3):1295-1301. https://doi.org/10.7314/APJCP.2015.16.3.1295
Kim, So Young ; Park, Jong Hyock ; Kang, Kyoung Hee ; Hwang, Inuk ; Yang, Hyung Kook ; Won, Young Joo ; Seo, Hong Gwan ; Lee, Dukhyoung ; Yoon, Seok-Jun. / The economic burden of cancer in Korea in 2009. In: Asian Pacific Journal of Cancer Prevention. 2015 ; Vol. 16, No. 3. pp. 1295-1301.
@article{f6a4f4b2c86e4c4da0d5a5f7a115c254,
title = "The economic burden of cancer in Korea in 2009",
abstract = "Background: Cancer imposes a significant economic burden on individuals, families and society. The purpose of this study was to estimate the economic burden of cancer using the healthcare claims and cancer registry data in Korea in 2009. Materials and Methods: The economic burden of cancer was estimated using the prevalence data where patients were identified in the Korean Central Cancer Registry. We estimated the medical, non-medical, morbidity and mortality cost due to lost productivity. Medical costs were calculated using the healthcare claims data obtained from the Korean National Health Insurance (KNHI) Corporation. Non-medical costs included the cost of transportation to visit health providers, costs associated with caregiving for cancer patients, and costs for complementary and alternative medicine (CAM). Data acquired from the Korean National Statistics Office and Ministry of Labor were used to calculate the life expectancy at the time of death, age- and gender-specific wages on average, adjusted for unemployment and labor force participation rate. Sensitivity analysis was performed to derive the current value of foregone future earnings due to premature death, discounted at 3{\%} and 5{\%}. Results: In 2009, estimated total economic cost of cancer amounted to $17.3 billion at a 3{\%} discount rate. Medical care accounted for 28.3{\%} of total costs, followed by non-medical (17.2{\%}), morbidity (24.2{\%}) and mortality (30.3{\%}) costs. Conclusions: Given that the direct medical cost sharply increased over the last decade, we must strive to construct a sustainable health care system that provides better care while lowering the cost. In addition, a comprehensive cancer survivorship policy aimed at lower caregiving cost and higher rate of return to work has become more important than previously considered.",
keywords = "Cancer, Cost analysis, Cost of illness, Health care costs, Korea",
author = "Kim, {So Young} and Park, {Jong Hyock} and Kang, {Kyoung Hee} and Inuk Hwang and Yang, {Hyung Kook} and Won, {Young Joo} and Seo, {Hong Gwan} and Dukhyoung Lee and Seok-Jun Yoon",
year = "2015",
month = "1",
day = "1",
doi = "10.7314/APJCP.2015.16.3.1295",
language = "English",
volume = "16",
pages = "1295--1301",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "3",

}

TY - JOUR

T1 - The economic burden of cancer in Korea in 2009

AU - Kim, So Young

AU - Park, Jong Hyock

AU - Kang, Kyoung Hee

AU - Hwang, Inuk

AU - Yang, Hyung Kook

AU - Won, Young Joo

AU - Seo, Hong Gwan

AU - Lee, Dukhyoung

AU - Yoon, Seok-Jun

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: Cancer imposes a significant economic burden on individuals, families and society. The purpose of this study was to estimate the economic burden of cancer using the healthcare claims and cancer registry data in Korea in 2009. Materials and Methods: The economic burden of cancer was estimated using the prevalence data where patients were identified in the Korean Central Cancer Registry. We estimated the medical, non-medical, morbidity and mortality cost due to lost productivity. Medical costs were calculated using the healthcare claims data obtained from the Korean National Health Insurance (KNHI) Corporation. Non-medical costs included the cost of transportation to visit health providers, costs associated with caregiving for cancer patients, and costs for complementary and alternative medicine (CAM). Data acquired from the Korean National Statistics Office and Ministry of Labor were used to calculate the life expectancy at the time of death, age- and gender-specific wages on average, adjusted for unemployment and labor force participation rate. Sensitivity analysis was performed to derive the current value of foregone future earnings due to premature death, discounted at 3% and 5%. Results: In 2009, estimated total economic cost of cancer amounted to $17.3 billion at a 3% discount rate. Medical care accounted for 28.3% of total costs, followed by non-medical (17.2%), morbidity (24.2%) and mortality (30.3%) costs. Conclusions: Given that the direct medical cost sharply increased over the last decade, we must strive to construct a sustainable health care system that provides better care while lowering the cost. In addition, a comprehensive cancer survivorship policy aimed at lower caregiving cost and higher rate of return to work has become more important than previously considered.

AB - Background: Cancer imposes a significant economic burden on individuals, families and society. The purpose of this study was to estimate the economic burden of cancer using the healthcare claims and cancer registry data in Korea in 2009. Materials and Methods: The economic burden of cancer was estimated using the prevalence data where patients were identified in the Korean Central Cancer Registry. We estimated the medical, non-medical, morbidity and mortality cost due to lost productivity. Medical costs were calculated using the healthcare claims data obtained from the Korean National Health Insurance (KNHI) Corporation. Non-medical costs included the cost of transportation to visit health providers, costs associated with caregiving for cancer patients, and costs for complementary and alternative medicine (CAM). Data acquired from the Korean National Statistics Office and Ministry of Labor were used to calculate the life expectancy at the time of death, age- and gender-specific wages on average, adjusted for unemployment and labor force participation rate. Sensitivity analysis was performed to derive the current value of foregone future earnings due to premature death, discounted at 3% and 5%. Results: In 2009, estimated total economic cost of cancer amounted to $17.3 billion at a 3% discount rate. Medical care accounted for 28.3% of total costs, followed by non-medical (17.2%), morbidity (24.2%) and mortality (30.3%) costs. Conclusions: Given that the direct medical cost sharply increased over the last decade, we must strive to construct a sustainable health care system that provides better care while lowering the cost. In addition, a comprehensive cancer survivorship policy aimed at lower caregiving cost and higher rate of return to work has become more important than previously considered.

KW - Cancer

KW - Cost analysis

KW - Cost of illness

KW - Health care costs

KW - Korea

UR - http://www.scopus.com/inward/record.url?scp=84929319138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929319138&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2015.16.3.1295

DO - 10.7314/APJCP.2015.16.3.1295

M3 - Article

C2 - 25735370

AN - SCOPUS:84929319138

VL - 16

SP - 1295

EP - 1301

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 3

ER -